Administrative and technical support for ongoing task area 3 studies and final transition
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $462,455
Award facts
- Opportunity
-
- 0012 Solicitation number
- CIVET/MANDRIL Software Maintenance Pre-Solicitation · Posted Jul 7, 2021
- Contract value 100% obligated
- $462,454.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$78,731 | |
| Funding Only Action | $35,416 | |
| Exercise an Option | $257,128 | |
| Original award | $248,642 |
About this award
This federal contract award, valued at $462,454.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 Indefinite Delivery Vehicle (IDV), and the work involves providing administrative and technical support for ongoing Task Area 3 studies and final transition. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIAID and the Department of Health and Human Services, to support the development of medical countermeasures for various infectious diseases. Through this contract, ABL will likely contribute its expertise in areas such as biologics manufacturing, testing, and quality assurance to support the agency's broader Simian Vaccine Evaluation Units program.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 30, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $462,455 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award